外侧关节外手术降低精英运动员前交叉韧带重建翻修风险:比较研究的系统综述与Meta分析
该系统综述与Meta分析比较了精英运动员中单纯前交叉韧带重建(ACLR)与ACLR联合外侧关节外手术(LEAP)的再断裂率。共纳入586例单纯ACLR运动员和417例联合LEAP运动员,结果显示联合LEAP组再断裂率5.0%显著低于单纯ACLR组14.0%(P=.042),汇总OR为0.35(95%CI,0.20-0.59;P<.001),即再断裂风险降低65%。作者认为,尽管纳入研究较少,精英运动员行ACLR时加做前外侧手术似可显著降低再断裂风险。
要点
- 精英运动员单纯ACLR再断裂率14.0%,联合LEAP组为5.0%,两组差异有统计学意义(P=.042)。
- 汇总OR为0.35(95%CI,0.20-0.59;P<.001),联合LEAP组再断裂风险降低65%。
- 作者认为,尽管纳入研究较少,治疗精英运动员时应仔细考虑LEAP以显著降低再断裂风险。
核心结论
- 在精英运动员中,ACLR时加做前外侧手术显著降低了再断裂率,并将再断裂风险降低超过60%。
- 尽管纳入研究较少,本研究似乎表明,外科医生在治疗精英运动员时应仔细考虑LEAP,以显著降低再断裂风险。
研究设计与样本
- 系统综述与Meta分析,证据等级3级,遵循PRISMA指南。
- 检索PubMed、Embase和Cochrane Library数据库,纳入分析精英运动员单纯ACLR与ACLR联合LEAP后再断裂率的比较研究。
- 采用MINORS(非随机研究方法学指数)评分进行质量评价,主要结局指标为同侧前交叉韧带再断裂。
主要发现
- 共586例精英运动员接受单纯ACLR,417例接受ACLR联合LEAP。
- 总体再断裂率为9.3%(95%CI,5.5%-14.0%)。
- ACLR组再断裂率为14.0%(95%CI,7.9%-21.5%),ACLR联合LEAP组为5.0%(95%CI,1.2%-10.8%),两组差异有统计学意义(P=.042)。
- 汇总OR显示,ACLR联合LEAP组发生新断裂事件的风险较ACLR组降低65%,OR为0.35(95%CI,0.20-0.59;P<.001)。
关键数值与推荐
- 主要结局指标为同侧ACL再断裂。
- 质量评价采用MINORS评分。
- 研究注册号:PROSPERO CRD42025637843。
临床怎么用
- 作者认为,尽管纳入研究较少,本研究似乎表明外科医生在治疗精英运动员时应仔细考虑LEAP,以显著降低再断裂风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lateral extra-articular procedures (LEAPs) have gained increasing attention as an adjunct to anterior cruciate ligament reconstruction (ACLR), particularly in individuals at high risk for reinjury. When combined with ACLR, LEAPs contribute to the restoration of normal knee kinematics and provide a significant reduction in residual anterior laxity compared with isolated ACLR. This added stability provides a protective effect on the intra-articular graft, promoting improved healing and integration while reducing mechanical stress on the reconstructed anterior cruciate ligament (ACL). As a result, these techniques have been demonstrated to result in improved performance after ACLR, higher graft survival, and lower revision rates, even in elite athletes who are at significant risk for reinjury. PURPOSE/HYPOTHESIS: The aim of this study was to systematically compare the existing evidence on ACL rerupture rates by performing a meta-analysis comparing combined ACLR and LEAP versus isolated ACLR in elite athletes. The primary hypothesis of this systematic review and meta-analysis was that the addition of LEAP would reduce the rate of revision ACLR in elite athletes. STUDY DESIGN: Systematic review and meta-analysis; Level of evidence, 3. METHODS: The method followed the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. The PubMed, Embase, and Cochrane Library databases were searched to identify potentially relevant comparative studies that analyzed rerupture rate in elite athletes after isolated ACLR versus ACLR plus LEAP. The MINORS (Methodological Index for Non-Randomized Studies) score was used for quality assessment. The main outcome measure was ipsilateral ACL rerupture. RESULTS: A total of 586 elite athletes received an isolated ACLR, whereas 417 athletes received combined ACLR plus LEAP. Rerupture was reported by 9.3% (95% CI, 5.5%-14.0%) of athletes. In the ACLR group, 14.0% (95% CI, 7.9%-21.5%) reported a rerupture, whereas in the ACLR plus LEAP group, the reinjury rate was 5.0% (95% CI, 1.2%-10.8%), with a statistically significant difference between the 2 groups (P = .042). Pooled odds ratio (OR) showed a 65% reduced risk of a new rupture episode in the ACLR plus LEAP group compared with the ACLR group, with an OR of 0.35 (95% CI, 0.20-0.59; P < .001). CONCLUSION: In elite athletes, adding an anterolateral procedure during ACLR significantly reduced the rerupture rate and reduced the risk of rerupture by >60%. Despite the few studies considered, our study seems to indicate that surgeons should carefully consider LEAP when treating an elite athlete in order to significantly reduce the risk of rerupture. REGISTRATION: PROSPERO: CRD42025637843.
引用
- D'Ambrosi R, Carrozzo A, Monaco E, et al. Lateral Extra-articular Procedures Reduce the Risk of Revision of Anterior Cruciate Ligament Reconstruction in Elite Athletes: A Systematic Review and Meta-analysis of Comparative Studies. Am J Sports Med. 2026. PMID: 41508654. doi:10.1177/03635465251376655
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。